Lucida Medical vs POURED Inc.: Revenue, Funding & Team Size Compared
Lucida Medical generates $615.8K in revenue; POURED Inc. generates $597.9K. Lucida Medical and POURED Inc. are close to the same size by revenue. The table below compares Lucida Medical and POURED Inc. on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $615.8K | $597.9K |
| Valuation | $3.7M | $6M |
| Team size | 17 | 3 |
| Founded | 2019 | 2019 |
| HQ | Cambridge, United Kingdom | Los Angeles, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Lucida Medical at a glance
Lucida Medical generates $615.8K in revenue with 17 employees, headquartered in Cambridge, United Kingdom.
- Revenue
- $615.8K
- Valuation
- $3.7M
- Team size
- 17
- Founded
- 2019
SaaS, Cancer Diagnosis, Radiology, MRI, Prostate Cancer
POURED Inc. at a glance
POURED Inc. generates $597.9K in revenue with 3 employees, headquartered in Los Angeles, United States.
- Revenue
- $597.9K
- Valuation
- $6M
- Team size
- 3
- Founded
- 2019
POURED is mobile app for iOS and Android leveraging first-of-its-kind algorithmic technology to automatically upload, aggregate and correlate wine list data in real-time with the click of a button. POURED was created by wine & spirits…
Other Lucida Medical alternatives
Lucida Medical competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Lucida Medical vs POURED Inc.: frequently asked questions
Is Lucida Medical or POURED Inc. bigger?
Lucida Medical is the bigger company by revenue, at $615.8K against $597.9K for POURED Inc..
How much revenue does Lucida Medical make?
Lucida Medical generates $615.8K in annual revenue with a team of 17.
How much revenue does POURED Inc. make?
POURED Inc. generates $597.9K in annual revenue with a team of 3.